Mister Spex, the German-based omnichannel retailer, has reported a double-digit increase in Q3 sales as compared to the same period last year, however falling below its own growth expectations as the prescription glasses’ business, which accounts for about 80 percent of the group’s revenues, underperformed.
Already an Eyewear Intelligence subscriber? Sign in here.
Buying a membership today will give you:
Or sign-up for a trial month for just 9,90€. To continue reading this article register now.